Updated Oct 2016 Angela Y. Chang Harvard T.H. Chan School of Public Health, Department of Global Health and Population [email protected] http://scholar.harvard.edu/angelachang/ Education 2017 (Expected) Doctor of Science, Global Health and Population, Harvard T.H. Chan School of Public Health 2011 Master of Health Administration, Johns Hopkins Bloomberg School of Public Health 2009 Bachelor of Science, Pharmaceutical Sciences, National Taiwan University 2008 Certificate, Pharmaceutical Sciences, Kyoto University Publications 1 Chang AY, Robinson LA, Hammitt JK, Resch S. 2016. The economics in “Global Health 2035:” a sensitivity analysis of the value of a life year estimates. Journal of Global Health. Forthcoming. 2 Robinson LA, Hammitt JK, Chang AY, Resch S. 2016. Understanding and improving the one and three times GDP per capita cost-effectiveness thresholds. Health Policy and Planning. 3 Hontelez JA, Chang AY, Ogbuoji O, de Vlas SJ, Bärnighausen T, Atun R. Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness. AIDS. 2016 Sep 24;30(15):2341-50. 4 Atun R, Chang AY, Ogbuoji O, et al. 2016. Long-term financing needs for HIV control in sub-Saharan Africa in 2015- 2050: a modelling study. BMJ Open;6: e009656. doi:10.1136/bmjopen-2015-009656 5 Bowser D, Chang AY, Bossert T, Mabirizi D. 2015. Assessing Facility-Level Practices and Behaviors That Affect Antiretroviral Medicines Supply Chain. Washington, DC MSH-SIAPS/USAID. 6 Chang AY, Røttingen JA, Hoffman SJ, Moon S. 2014. Governance Arrangements for Health R&D. Geneva, Switzerland: Graduate Institute of International & Development Studies and Cambridge, MA: Harvard Global Health Institute. Working Papers and Ongoing Research Chang AY, Haber N, Bärnighausen T, Salomon J. 2016. Modeling health system barriers in global health: incorporating leakages and delays in the HIV treatment cascade. Chang AY, Gomez-Olive FX, Salomon J. 2016. Epidemiology and determinants of multimorbidity and its impact on physical and mental functioning among older population in rural South Africa. Chang AY, Gomez-Olive FX, Salomon J. 2016. The effect of concordant and discordant diseases on effective coverage for hypertension, diabetes, and HIV among older adults with multimorbidity in Agincourt, South Africa. Chang AY, Jamison D. 2016. Defining and estimating health adjusted income. Chang AY, Jamison D. 2016. Benefit Cost Analysis in the Disease Control Priorities (DCP3). Vol 9 Chp 15. Submitted. Chang AY, Riumallo-Herl C, Verguet S. 2016. Modeling the distribution of vaccine-preventable childhood morbidity and mortality. Chang AY, Ogbuoji O, Atun R, Verguet S. 2016. Modeling approaches to capture health system performance: a systematic review of the literature. Submitted. Chang AY, Eaton J, Salomon S. 2016. Revisiting cost-effectiveness estimates for scaling up ART: the example of home- based HIV counselling and testing in high prevalence settings. Chang AY, Bump JB. 2016. The Ascendance of Universal Health Coverage on the Global Health Agenda – a Political Economy Analysis. Bump JB, Chang AY. 2016. A Political Economy Framework for Analyzing Health Benefit Package Decisions. Draft chapter for Center for Global Development’s book “What services should health systems provide? Health benefits plans in low- and middle-income countries.” Riumallo-Herl C, Chang AY, Verguet S. 2016. Estimating the financial risk protection and poverty alleviation benefits of vaccines. Ogbuoji O, Chang AY, Atun R, Verguet S. 2016.Quantifying Health System Performance in Low- and Middle-Income Countries: A Systematic Analysis of Coverage Levels and Rates of Change. Bowser D, Krech L, Mabirizi D, Chang AY, Bossert T. 2016. Practices and Behaviors at the Health Facility Level that Influence Supply Chain Management for Antiretrovirals: Evidence from Namibia, Cameroon, and Swaziland. 1 Updated Oct 2016 Teaching 2014 Teaching Assistant, Applied Political Analysis in Global Health. Instructor: Michael Reich 2014 Teaching Assistant, Supply Chain Management in Global Health. Instructors: Erin Hasselberg, Michael Reich 2013 Teaching Assistant, Social and and Economic Dimensions of Infectious Diseases. Instructor: Richard Cash 2013 Teaching Assistant, Introduction to Decision Science. Instructor: Joe Pliskin Fellowships, Grants, and Awards 2016 Clarence James and Sarah Bradley Gamble Endowment Scholarship 2016 Emerging Voices for Global Health (EV4GH), Health Systems Global 2014 Barry R. and Irene Tilenius Bloom Fellowship 2012-2014 Doctoral fellowship, Ministry of Education, Taiwan. 2011 Delta Omega, Johns Hopkins School of Public Health. Awarded to top 10% of graduating class 2008-2009 Two-time recipient of Outstanding College Youth Award at National Taiwan University 2008 Recipient of Dedication to Public Service Award, Ministry of Health, Taiwan Professional Experience 2013, 2014 Bill and Melinda Gates Foundation, Seattle WA Intern, Integrated Delivery, with Dr. Damian Walker Intern, Office of the President for Global Health, with Dr. Niranjan Bose 2015-2016 Disease Control Priority Project, Research Assistant to Professor Dean Jamison, Seattle, WA 2010-2012 Deloitte Consulting LLC, Senior Consultant, Healthcare Life Sciences, Strategy & Operations, Boston, MA Invited Presentations 2016 Global Symposium on Health Systems Research, panelist 2016 Society for Benefit-Cost Analysis Annual conference, panelist “What is a Life Year Worth? Sensitivity of Lancet Commission on Investing in Health Estimates” 2016 Prince Mahidol Award Conference, panelist “Framework for Analyzing the Political Economy of Health Benefit Packages” 2016 Gavi The Vaccine Alliance, panelist “Estimating Disease Risk Indices and Number of Deaths Averted by Vaccines and Income Quintile” 2015 Yang-Ming University, faculty seminar presenter “Incorporating Implementation Challenges in Modeling Health Benefits in Global Health” 2015 Center for Global Development, workshop presenter “A Political Economy Framework for Analyzing Health Benefit Package Decisions” 2015 Economic Evaluation in Health: Cost-Effectiveness and Beyond Workshop, Harvard University, panelist “Sensitivity of Lancet Commission on Investing in Health estimates to underlying assumptions” 2014 Stakeholder Dialogue on the National Health Insurance Scheme Benefits Package, National Health Insurance Authority, Ghana, panelist and discussant on plenary sessions 2014 USAID, workshop speaker “Assessing Facility-Level Practices and Behaviors That Affect Antiretroviral Medicines Supply Chain” 2013 The Graduate Institute Geneva, workshop speaker. “Governance Arrangements for Health R&D” Others Journal reviewer PLoS One, Social Science & Medicine Professional affiliations Population Association of America (PAA), International Health Economics Association (iHEA), Health Technology Assessment International (HTAi), Health Systems Global, Society for Benefit- Cost Analysis (SBCA) Languages English, Mandarin Chinese, Japanese, Taiwanese (native), Italian (beginner) Programming language R, Stata Personal information Taiwanese citizen, eligible to work in the United States. Eligible for Italian and Japanese citizenship. References Professor Michael Reich, Harvard T.H. Chan School of Public Health; [email protected] Professor Joshua Salomon, Harvard T.H. Chan School of Public Health; [email protected] Professor Dean Jamison, University of Washington; [email protected] Professor Rifat Atun, Harvard T.H. Chan School of Public Health; [email protected] 2 .